405 related articles for article (PubMed ID: 38646648)
21. Theranostics in immuno-oncology using nanobody derivatives.
Lecocq Q; De Vlaeminck Y; Hanssens H; D'Huyvetter M; Raes G; Goyvaerts C; Keyaerts M; Devoogdt N; Breckpot K
Theranostics; 2019; 9(25):7772-7791. PubMed ID: 31695800
[TBL] [Abstract][Full Text] [Related]
22. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
23. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
Muthu MS; Mehata AK; Viswanadh MK
Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
[No Abstract] [Full Text] [Related]
24. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
25. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
26. Nanomedicine strategies for molecular targets with MRI and optical imaging.
Pan D; Caruthers SD; Chen J; Winter PM; SenPan A; Schmieder AH; Wickline SA; Lanza GM
Future Med Chem; 2010 Mar; 2(3):471-90. PubMed ID: 20485473
[TBL] [Abstract][Full Text] [Related]
27. Automation: A revolutionary vision of artificial intelligence in theranostics.
Gulsheen P; Batra S; Sharma S
Bull Cancer; 2023 Feb; 110(2):233-241. PubMed ID: 36509576
[TBL] [Abstract][Full Text] [Related]
28. Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer.
Ahn BC
Biomed Res Int; 2016; 2016():1680464. PubMed ID: 27239470
[TBL] [Abstract][Full Text] [Related]
29. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography image-guided drug delivery: current status and future perspectives.
Chakravarty R; Hong H; Cai W
Mol Pharm; 2014 Nov; 11(11):3777-97. PubMed ID: 24865108
[TBL] [Abstract][Full Text] [Related]
31. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
Moorthy H; Govindaraju T
ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
[TBL] [Abstract][Full Text] [Related]
32. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.
Wang S; He H; Mao Y; Zhang Y; Gu N
Adv Sci (Weinh); 2024 May; 11(17):e2308298. PubMed ID: 38368274
[TBL] [Abstract][Full Text] [Related]
33. Magnetic nanoparticles for cancer theranostics: Advances and prospects.
Li X; Li W; Wang M; Liao Z
J Control Release; 2021 Jul; 335():437-448. PubMed ID: 34081996
[TBL] [Abstract][Full Text] [Related]
34. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
35. One stone, many birds: Recent advances in functional nanogels for cancer nanotheranostics.
Wang H; Picchio ML; Calderón M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1791. PubMed ID: 35338603
[TBL] [Abstract][Full Text] [Related]
36. Special Issue "Recent Advances in Precision Nanomedicine for Cancer".
Brignole C; Pastorino F
Molecules; 2020 Sep; 25(18):. PubMed ID: 32927825
[TBL] [Abstract][Full Text] [Related]
37. Towards tailored management of malignant brain tumors with nanotheranostics.
Aparicio-Blanco J; Torres-Suárez AI
Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
[TBL] [Abstract][Full Text] [Related]
39. Artificial Molecular Machines in Nanotheranostics.
Yu G; Yung BC; Zhou Z; Mao Z; Chen X
ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
[TBL] [Abstract][Full Text] [Related]
40. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.
Cabral RM; Baptista PV
Expert Rev Mol Diagn; 2014 Nov; 14(8):1041-52. PubMed ID: 25314939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
